Biftek, CULT Food Science Holding Company, Provides Marketing Advice on Its Growth Medium Supplement

Biftek’s formulation is expected to dramatically reduce the cost of creating food products based on cellular agriculture and facilitate the achievement of economies of scale to catapult cultivated meat into the mainstream.

VANCOUVER, BC, November 29, 2021 / CNW / – CULT Food Science Corp. (“CULT” or the “Company”), an innovative investment platform focused exclusively on clean, laboratory-grown foods that advances the development of new technologies to provide a sustainable, environmental and ethical solution to global crises in factory farming and aquaculture, is pleased to announce that its holding company Biftek Inc. (“Biftek“or the”Holding company“) recently reported significant progress related to the commercialization and viability of its new growth medium supplement product lines (the”Growth mediumCULT’s holding company recently arranged for the transport of an inaugural sample that will serve as the cornerstone of a business collaboration with a leading cultured meat company based in Singapore.

CULT Food Science Corp. (CNW Group / CULT Food Science Corp.)

The new formulation of Biftek, with the trade name “Lyophilized Biftek Growth Medium Supplement”, has been scientifically designed to be shipped worldwide without the need for cold chain logistics and without variation between batches, thus ensuring consistent quality between lots. Growing media are an important pillar for the massive adoption of cultured meat globally, which are essential to help achieve material cost reductions, improved efficiency, and consistent food products.

Founded in 2018 and based in Ankara, Turkey, Biftek produces a natural, animal-free, non-GMO growth medium supplement to make cultured meat more affordable. A business-to-business company, Biftek uses a novel culture medium supplement formula to grow muscle stem cells. Currently, the growth of stem cells requires conventional fetal-bovine serum (“FBS“), which accounts for 80-90% of production costs. Biftek’s formulation is expected to significantly reduce expenses related to the creation of cellular agriculture products, thereby enabling food technology companies to reduce production costs, achieve economies of scale and help catapult meat cultures into mainstream use cases.

Management commentary

“This is a crucial step for Biftek towards the validation of new formulations and commercialization on a global scale. We are delighted to see Biftek’s scientific innovations emerge from the lab and into the production facilities of cultured meat producers. Biftek’s continued contributions as a leading innovator and thought leader in the growth media vertical industry are indicative of CULT’s ability to seek out and partner with leading CellAg companies, both in countries and abroad, ”commented Dr. Paul burridge, advisor to CULT.

“The current challenges within the cultured meat ecosystem are fragmented. We believe that the most important thing is to reduce the production cost of cultivated meat products and we have developed several potential solutions to solve this problem. the most powerful tools to ensure mass adoption of lab-grown foods. Biftek’s growth medium supplement is fast becoming one of the best alternatives to FBS, ”said Kerem Erikci, CEO of Biftek.

About Biftek

Biftek focuses on the production of a natural and cost-effective microorganism-based growth medium supplement for the growth of muscle stem cells. Instead of conventional fetal bovine serum (FBS) dependent production, which accounts for almost 90% of the cost, Biftek’s patent pending formulation dramatically reduces the associated expense, introducing a much better and more efficient way to grow crops. meat at an affordable price.

About CULT Food Science

CULT Food Science Corp. is an innovative investment platform focused exclusively on clean, laboratory-grown food that advances the development of new technologies to provide a sustainable, environmental and ethical solution to the global factory farming crisis. The first of its kind in North America, CULT Food Science aims to provide individual investors with unprecedented exposure to the most innovative start-ups, private or start-up companies producing cultured meat and cultured dairy products across the world.

Additional information can be found by visiting the Company’s website at or its regulatory documents at

On behalf of the Board of Directors of the Company,


“Dorian banks”
Dorian banks, CEO

Forward-looking information:

The information contained in this press release may involve forward-looking statements. Forward-looking statements are statements that relate to future events and not past. In this context, forward-looking statements often deal with the expected future business and financial performance of a business and often contain words such as “anticipate”, “believe”, “plan”, “estimate”, “expect” and “ intend ”, statements that an action or event“ could ”,“ could ”,“ could ”,“ should ”or“ will ”be taken or occur, or other similar expressions. By their very nature, forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements, or other future events, to be materially different from results, performances. or future achievements expressed or implied by these forward-looking statements. These factors include, but are not limited to, the following risks: those associated with the marketing and sale of securities; the need for additional financing; the use of key personnel; the potential for conflicts of interest between certain officers or directors with certain other projects; and the volatility of the price and volume of common shares. Forward-looking statements are based on the beliefs, estimates and opinions of management at the date the statements are made and, except as required by law, the Company assumes no obligation to update any forward-looking statements. if these beliefs, estimates and opinions or other circumstances should change. Investors are cautioned against assigning undue certainty to forward-looking statements. For further information on risk, investors are encouraged to consult the Company’s MD&A and other disclosure documents filed with regulatory authorities which can be found at

SOURCE CULT Food Science Corp.



View original content to download multimedia:

About Harold Hartman

Check Also

Liverpool fans hail ‘cult hero’ Kostas Tsimikas as Lucas Leiva backs new No.21 – Liverpool FC

Kostas Tsimikas was the hero at Wembley as his kick sealed the FA Cup triumph …